Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IDXX | TMO | ISRG | FMS | EW |
| Company | Idexx Laboratories | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Fresenius Medical Care Ag ADR | Edwards Lifesciences Corp |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NYSE |
| Open | 482.20 | 542.95 | 385.27 | 19.23 | 87.20 |
| High | 482.21 | 546.14 | 388.65 | 19.60 | 87.20 |
| Low | 471.42 | 539.17 | 364.17 | 19.23 | 85.38 |
| Last | 476.35 | 544.78 | 366.34 | 19.54 | 85.94 |
| Change | -1.44 | +3.26 | -6.29 | +0.15 | -0.51 |
| % Change | -0.30% | +0.60% | -1.69% | +0.77% | -0.59% |
| Volume | 565,411 | 1,738,307 | 3,803,348 | 458,574 | 3,870,469 |
| 20-Day Average Volume | 394,235 | 1,257,713 | 1,555,335 | 315,515 | 2,957,852 |
| Previous Close | 477.79 | 541.52 | 372.63 | 19.39 | 86.45 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 511.84 | 569.48 | 386.17 | 18.96 | 91.70 |
| 20-Day Raw Stochastic | 3.61% | 26.84% | 6.21% | 96.87% | 5.03% |
| 20-Day Relative Strength | 26.63% | 39.65% | 39.91% | 52.67% | 41.23% |
| Weighted Alpha | -6.96 | -1.20 | +22.78 | -14.27 | +4.30 |
| Today's Opinion | 24% Sell | 24% Buy | 40% Buy | 72% Sell | 56% Buy |
| Previous Opinion | 24% Sell | 40% Buy | 56% Buy | 88% Sell | 56% Buy |
| Last Month's Opinion | 56% Buy | 88% Buy | 100% Buy | 72% Sell | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.78% since 04/12/24 | -3.43% since 04/12/24 | -4.72% since 04/12/24 | +6.36% since 04/12/24 | -4.83% since 04/12/24 |
| Low | 471.42 on 04/19/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 18.48 on 04/16/24 | 85.38 on 04/19/24 |
| High | 506.57 on 04/15/24 | 570.72 on 04/15/24 | 392.29 on 04/15/24 | 19.60 on 04/19/24 | 91.73 on 04/15/24 |
| 1-Month | |||||
| %Chg | -11.30% since 03/19/24 | -6.33% since 03/19/24 | -6.12% since 03/19/24 | +0.15% since 03/19/24 | -8.90% since 03/19/24 |
| Low | 471.42 on 04/19/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 18.32 on 04/12/24 | 85.38 on 04/19/24 |
| High | 543.33 on 03/28/24 | 589.93 on 04/09/24 | 403.76 on 03/27/24 | 19.70 on 03/20/24 | 96.12 on 03/28/24 |
| 3-Month | |||||
| %Chg | -9.51% since 01/19/24 | -1.07% since 01/19/24 | -2.19% since 01/19/24 | +0.05% since 01/19/24 | +15.62% since 01/19/24 |
| Low | 471.42 on 04/19/24 | 529.64 on 04/18/24 | 362.14 on 01/24/24 | 18.32 on 04/12/24 | 71.92 on 01/25/24 |
| High | 583.39 on 03/01/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 21.48 on 02/14/24 | 96.12 on 03/28/24 |
| 6-Month | |||||
| %Chg | +11.35% since 10/19/23 | +16.21% since 10/19/23 | +34.08% since 10/19/23 | +12.41% since 10/19/23 | +24.38% since 10/19/23 |
| Low | 372.50 on 11/01/23 | 415.60 on 10/25/23 | 254.85 on 10/30/23 | 16.37 on 10/27/23 | 60.57 on 10/30/23 |
| High | 583.39 on 03/01/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 21.52 on 12/14/23 | 96.12 on 03/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 39,682,372 | 206,705,760 | 132,078,328 | 11,378,576 | 52,036,584 |
| Shares Outstanding, K | 83,054 | 381,714 | 354,449 | 586,827 | 601,927 |
| Annual Sales | 3,660,950,000 | 42,857,000,000 | 7,124,100,000 | 21,054,650,000 | 6,004,800,000 |
| Annual Net Income | 845,040,000 | 5,995,000,000 | 1,798,000,000 | 540,060,000 | 1,402,400,000 |
| Last Quarter Sales | 901,600,000 | 10,886,000,000 | 1,928,300,000 | 5,371,060,000 | 1,534,100,000 |
| Last Quarter Net Income | 194,520,000 | 1,630,000,000 | 606,200,000 | 202,510,000 | 369,900,000 |
| 60-Month Beta | 1.26 | 0.80 | 1.36 | 1.00 | 1.05 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.32 on 02/05/24 | 5.67 on 01/31/24 | 1.50 on 04/18/24 | 0.47 on 02/20/24 | 0.64 on 02/06/24 |
| Latest Earnings Date | 05/01/24 | 04/24/24 | 04/18/24 | 05/14/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | 0.415 on 05/17/23 | N/A |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | 05/17/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 47.49 | 25.41 | 82.78 | 13.75 | 34.76 |